Biocryst Pharmaceuticals Inc (BCRX)

EBITDA Margin

-32.21%

TTM · Period ending:

BCRX logo

BCRX EBITDA Margin

Latest reported-32.21%
BCRX TTM EBITDA Margin (-1066.67% → -32.21%)
High-resolution chart · PNG

BCRX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-32.2083%
-42.1409%
40.1563%
13.9831%
11.3791%
9.4527%
2.8417%
-5.8449%
-11.4748%
-28.6093%
-35.1028%
-38.6672%
-42.5807%
-41.063%
-53.1166%
-40.1854%
-61.1182%
-63.9773%
-77.4563%
-157.7393%
-225.0796%
-574.5164%
-938.9906%
-209.0749%
-210.5053%
-214.4879%
-197.1557%
-1,028.3892%
-993.584%
-425.8465%
-442.0956%
-383.3135%
-238.2418%
-344.4157%
-224.3826%
-137.3328%
-132.0094%
-125.3019%
-174.0219%
-276.197%
-253.8498%
-94.6963%
-79.9905%
-64.9539%
-63.3706%
-264.9387%
-294.0476%
-180.6076%
-185.755%
-178.4392%
-145.0638%
-260.2853%
-205.7948%
-166.4416%
-117.2631%
-319.2625%
-342.9564%
-360.7136%
-518.6733%
-151.2353%
-119.1526%
-98.2753%
-51.4406%
-7.4275%
-7.1539%
-5.6964%
-16.2553%
-32.1476%
-30.9899%
-41.6164%
-45.152%
-76.4788%
-66.12%
-48.564%
-31.5045%
-66.7489%
-131.5745%
-262.3918%
-743.1829%
-1,036.9721%
-1,442.1572%
-3,318.898%
-17,325.8614%
12,356.592%
-58,640.714%
-10,918.3889%
-6,319.7844%
-1,235.0598%
-1,134.6365%
-963.0392%
-709.7919%
-951.6551%
-813.9383%
-837.2499%
-888.5849%
-323.7174%
-158.4664%
-65.3385%
-37.5086%
-109.1947%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.